Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA.

Cancer Cell. 2012 Dec 11;22(6):709-24. doi: 10.1016/j.ccr.2012.10.012. Epub 2012 Nov 29.

2.

SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.

Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B.

Cancer Res. 2012 Sep 1;72(17):4597-608. doi: 10.1158/0008-5472.CAN-12-1045. Epub 2012 Jul 11.

3.

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Br J Cancer. 2013 Jul 23;109(2):307-11. doi: 10.1038/bjc.2013.339. Epub 2013 Jun 27.

4.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
5.

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.

Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J.

Cancer Res. 2008 Feb 15;68(4):989-97. doi: 10.1158/0008-5472.CAN-07-2017.

6.

PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.

Guo J, Fu Z, Wei J, Lu W, Feng J, Zhang S.

Med Oncol. 2015 Jan;32(1):393. doi: 10.1007/s12032-014-0393-x. Epub 2014 Nov 27.

PMID:
25428393
7.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA.

Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789. Review.

8.

Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer.

Zheng L, Zhang Y, Lin S, Sun A, Chen R, Ding Y, Ding Y.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10534-44. eCollection 2015.

9.

Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J.

Cancer Cell. 2012 Dec 11;22(6):725-36. doi: 10.1016/j.ccr.2012.09.022. Epub 2012 Nov 29.

10.

Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.

Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, Brand K, Steinert G, Schneider M, Mollenhauer M, Reissfelder C, Klupp F, Fritzmann J, Wunder C, Benner A, Kloor M, Huth C, Contin P, Ulrich A, Koch M, Weitz J.

Clin Cancer Res. 2011 Dec 15;17(24):7654-63. doi: 10.1158/1078-0432.CCR-10-2816. Epub 2011 Oct 31.

11.

[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].

Yoshida GJ, Saya H.

Clin Calcium. 2011 Mar;21(3):411-7. doi: CliCa1103411417. Review. Japanese.

PMID:
21358063
12.

Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.

Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH.

J Pathol. 2012 Oct;228(2):158-69. doi: 10.1002/path.3988. Epub 2012 May 23.

PMID:
22247069
13.

Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.

Lou Y, Preobrazhenska O, auf dem Keller U, Sutcliffe M, Barclay L, McDonald PC, Roskelley C, Overall CM, Dedhar S.

Dev Dyn. 2008 Oct;237(10):2755-68. doi: 10.1002/dvdy.21658.

14.

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.

Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.

15.

Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.

Zhang W, Jiang B, Guo Z, Sardet C, Zou B, Lam CS, Li J, He M, Lan HY, Pang R, Hung IF, Tan VP, Wang J, Wong BC.

Carcinogenesis. 2010 Jul;31(7):1220-9. doi: 10.1093/carcin/bgq094. Epub 2010 May 11.

PMID:
20460358
16.

Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.

Akalay I, Janji B, Hasmim M, Noman MZ, André F, De Cremoux P, Bertheau P, Badoual C, Vielh P, Larsen AK, Sabbah M, Tan TZ, Keira JH, Hung NT, Thiery JP, Mami-Chouaib F, Chouaib S.

Cancer Res. 2013 Apr 15;73(8):2418-27. doi: 10.1158/0008-5472.CAN-12-2432. Epub 2013 Feb 22.

17.

Generation of breast cancer stem cells through epithelial-mesenchymal transition.

Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A.

PLoS One. 2008 Aug 6;3(8):e2888. doi: 10.1371/journal.pone.0002888.

18.

Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.

Guha M, Srinivasan S, Ruthel G, Kashina AK, Carstens RP, Mendoza A, Khanna C, Van Winkle T, Avadhani NG.

Oncogene. 2014 Nov 6;33(45):5238-50. doi: 10.1038/onc.2013.467. Epub 2013 Nov 4.

19.

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.

Scheel C, Weinberg RA.

Semin Cancer Biol. 2012 Oct;22(5-6):396-403. doi: 10.1016/j.semcancer.2012.04.001. Epub 2012 Apr 23. Review.

PMID:
22554795
20.

A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.

Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noël A, Foidart JM, Birembaut P, Polette M, Gilles C.

Oncogene. 2012 Aug 16;31(33):3741-53. doi: 10.1038/onc.2011.540. Epub 2011 Nov 28.

PMID:
22120722

Supplemental Content

Support Center